Given the important roles of DNMT3B in cancer risk, it was biologically possible that DNMT3B polymorphism is associated with the risk of cancer by increasing DNMT3B promoter activity that modulated an aberrant de novo methylation of CpG islands in some tumor suppressor genes [4]. Here, DNMT3B is linked to cancer.